Erythroid development of the FDCP-Mix A4 multipotent cell line is governed by the relative concentrations of erythropoietin and interleukin 3.

2.50
Hdl Handle:
http://hdl.handle.net/10541/97459
Title:
Erythroid development of the FDCP-Mix A4 multipotent cell line is governed by the relative concentrations of erythropoietin and interleukin 3.
Authors:
Heyworth, Clare M; Alauldin, Mazin; Cross, Michael A; Fairbairn, Leslie J; Dexter, T Michael; Whetton, Anthony D
Abstract:
Conditions are described which promote the erythroid development of the FDCP-Mix A4 (A4) cell line with accompanying proliferation of the cells. The requirements for this development are low concentrations of interleukin 3 (IL-3) plus the presence of erythropoietin (epo) and haemin. When high concentrations of IL-3 are added with erythropoietin and haemin the cells do not differentiate and maintain their blast cell morphology. Addition of haemin, in the absence of erythropoietin, does not promote erythroid development, but the presence of haemin with erythropoietin promotes increased proliferation and maturation. The morphological maturation of A4 cells along the erythroid lineage is accompanied by a gradual loss of clonogenic potential, loss of A4 cell multipotency, increased erythropoietin receptor expression, and an increased expression of the beta-globin gene. An initial increase in mitogenic responsiveness to erythropoietin is followed by a decrease as the cells become refractory to all mitogenic stimuli with the acquisition of a postmitotic, mature erythroid cell phenotype.
Affiliation:
Cancer Research Campaign Department of Experimental Haematology, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester.
Citation:
Erythroid development of the FDCP-Mix A4 multipotent cell line is governed by the relative concentrations of erythropoietin and interleukin 3. 1995, 91 (1):15-22 Br. J. Haematol.
Journal:
British Journal of Haematology
Issue Date:
Sep-1995
URI:
http://hdl.handle.net/10541/97459
DOI:
10.1111/j.1365-2141.1995.tb05238.x
PubMed ID:
7577622
Type:
Article
Language:
en
ISSN:
0007-1048
Appears in Collections:
All Paterson Institute for Cancer Research

Full metadata record

DC FieldValue Language
dc.contributor.authorHeyworth, Clare Men
dc.contributor.authorAlauldin, Mazinen
dc.contributor.authorCross, Michael Aen
dc.contributor.authorFairbairn, Leslie Jen
dc.contributor.authorDexter, T Michaelen
dc.contributor.authorWhetton, Anthony Den
dc.date.accessioned2010-04-27T13:35:37Z-
dc.date.available2010-04-27T13:35:37Z-
dc.date.issued1995-09-
dc.identifier.citationErythroid development of the FDCP-Mix A4 multipotent cell line is governed by the relative concentrations of erythropoietin and interleukin 3. 1995, 91 (1):15-22 Br. J. Haematol.en
dc.identifier.issn0007-1048-
dc.identifier.pmid7577622-
dc.identifier.doi10.1111/j.1365-2141.1995.tb05238.x-
dc.identifier.urihttp://hdl.handle.net/10541/97459-
dc.description.abstractConditions are described which promote the erythroid development of the FDCP-Mix A4 (A4) cell line with accompanying proliferation of the cells. The requirements for this development are low concentrations of interleukin 3 (IL-3) plus the presence of erythropoietin (epo) and haemin. When high concentrations of IL-3 are added with erythropoietin and haemin the cells do not differentiate and maintain their blast cell morphology. Addition of haemin, in the absence of erythropoietin, does not promote erythroid development, but the presence of haemin with erythropoietin promotes increased proliferation and maturation. The morphological maturation of A4 cells along the erythroid lineage is accompanied by a gradual loss of clonogenic potential, loss of A4 cell multipotency, increased erythropoietin receptor expression, and an increased expression of the beta-globin gene. An initial increase in mitogenic responsiveness to erythropoietin is followed by a decrease as the cells become refractory to all mitogenic stimuli with the acquisition of a postmitotic, mature erythroid cell phenotype.en
dc.language.isoenen
dc.subjectHaematopoietic Stem Cellsen
dc.subject.meshBlotting, Northern-
dc.subject.meshCell Differentiation-
dc.subject.meshCell Line-
dc.subject.meshDose-Response Relationship, Drug-
dc.subject.meshErythroblasts-
dc.subject.meshErythropoietin-
dc.subject.meshGlobins-
dc.subject.meshHematopoietic Stem Cells-
dc.subject.meshHemin-
dc.subject.meshHumans-
dc.subject.meshInterleukin-3-
dc.subject.meshKinetics-
dc.subject.meshReceptors, Erythropoietin-
dc.subject.meshRecombinant Proteins-
dc.titleErythroid development of the FDCP-Mix A4 multipotent cell line is governed by the relative concentrations of erythropoietin and interleukin 3.en
dc.typeArticleen
dc.contributor.departmentCancer Research Campaign Department of Experimental Haematology, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester.en
dc.identifier.journalBritish Journal of Haematologyen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.